Skip to main content
MapleLMS Implementation
Conferences and Meetings 801. Gene Therapies: Poster III

801. Gene Therapies: Poster III

Short name: 801. Gene Therapies: Poster III
Course start date: 11/04/2025

Sections

General
0 activities

Deciphering Hematopoietic Reconstitution Dynamics of Lentiviral Vector HBBT87Q-Engineered Hematopoietic Stem Cells Gene Therapy for β-Thalassemia Patients
Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease
Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor
Valoctocogene Roxaparvovec Estimated Long-Term Durability of Treatment Effect: An Extrapolation of the Most Recent Clinical Data